Navigation Links
Eclipse Announces Partnership with Human Med USA, Manufacturers of Revolutionary Body-Jet(R)
Date:10/13/2009

DALLAS, Oct. 13 /PRNewswire/ -- Eclipsemed Ltd, a leading national supplier of advanced medical and aesthetic equipment, has announced its recent partnership with Human Med USA. Human Med AG of Germany, a leading manufacturer of medical and aesthetic devices including the revolutionary Body-Jet®, has formed Human Med USA to partner with Eclipse to increase efforts to sell Body-Jet® in the United States and North America.

"With the exceptionally strong sales advancement of Body-Jet in the United States, Human Med saw an opportunity to further support this unprecedented growth. By forming a partnership alliance to enhance the Eclipse effort, we believe this team concept shall be a supportive foundation for the significant increase in projected revenue," says Arnd Kensy, CEO Human Med AG.

Tom O'Brien, CEO Eclipsemed adds, "Human Med's willingness to create a US subsidiary to support our explosive growth is an indicator of their confidence in the Body-Jet's future and the Eclipse rapid market penetration. Opportunities to transform an entire market in a short time are usually rare events. Together such an opportunity will certainly be realized."

About Eclipsemed Ltd.

Eclipse is a leading supplier of aesthetic high-tech medical devices and related products. Eclipse has established a reputation as a trend setter on the national aesthetic market scene. The recent launch of the Body-Jet, water jet assisted liposuction technology is the most current example of how Eclipse has established itself as a undeniable force in bringing innovative products to market. Through its own direct sales force and team of independent agents, Eclipse continues to introduce products and solutions to the aesthetic marketplace. www.eclipsemed.com

About Human Med AG

Human Med is a leading manufacturer of medical and aesthetic devices that minimize surgery time as well as recovery periods. Human Med has gained international notoriety with the revolutionary Body-Jet®. They continue to seek a stronger cooperation with product users in order to develop new applications for water jet technology and to break into additional disciplines of medicine.

SOURCE Eclipsemed Ltd.


'/>"/>
SOURCE Eclipsemed Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the ... In terms of the latter, setting the bar too high can result in disappointment, ... just slow progress toward their goal. , Research from PsychTests.com reveals ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Comfort ... the American Cancer Society and the Road To Recovery® program to drive cancer patients ... seniors and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty ... Barry M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... and the most handsome men, look naturally attractive. Plastic surgery should be invisible.” ...
Breaking Medicine News(10 mins):